A Comparison of the Randomized Clinical Trial Efficacy and Real-World Effectiveness of Tofacitinib for the Treatment of Inflammatory Bowel Disease: A Cohort Study is a research paper published in medRxiv (2019). On theSindex it has a DataRank of 0.238. It has been cited 2 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0731
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: 5T32DK007007-36
INRSA Training Grant in Gastroenterology
National Institutes of Health
Grant: 5UL1TR001872-02
Clinical and Translational Science Institute
Fields of Study
Sustainable Development Goals
Utility of routinely collected electronic health records data to support effectiveness evaluations in Inflammatory Bowel Disease: A pilot study of Tofacitinib